Peter M Bingham
Affiliation: University of Vermont
- Pilot trial of spirometer games for airway clearance practice in cystic fibrosisPeter M Bingham
Department of Neurology, University of Vermont, Burlington, Vermont, USA
Respir Care 57:1278-84. 2012..We developed gaming technology that encourages forced expiratory maneuvers...
- Deprivation and dysphagia in premature infantsPeter M Bingham
Department of Neurology, University of Vermont, Burlington, Vermont 05401, USA
J Child Neurol 24:743-9. 2009..Studies exploring the link between early dysphagia and later developmental impairment could clarify experiential antecedents of cerebral injury. Trials of sensory interventions to promote feeding development are warranted...
- A breath biofeedback computer game for children with cystic fibrosisPeter M Bingham
University of Vermont, Burlington, USA
Clin Pediatr (Phila) 49:337-42. 2010..026). It was concluded that an electronic breath game is safe and can improve breath awareness among children with CF. This technology could also contribute to awareness of respiratory symptoms and foster social ties among CF patients...
- Prospective study of non-nutritive sucking and feeding skills in premature infantsPeter M Bingham
Fletcher Allen Health Care University of Vermont, 1 South Prospect, Burlington, VT 05401, USA
Arch Dis Child Fetal Neonatal Ed 95:F194-200. 2010....
- Breast milk odor via olfactometer for tube-fed, premature infantsPeter M Bingham
Fletcher Allen Health Care, University of Vermont, Burlington, Vermont 05401, USA
Behav Res Methods 39:630-4. 2007..These results indicate the feasibility and potential of this experimental approach, and warrant further study of the effect of controlled nutrient odor exposure on feeding behavior of premature infants...
- A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastomaGiselle L Saulnier Sholler
Department of Pediatrics, Vermont Children s Hospital, Burlington, VT, USA
J Pediatr Hematol Oncol 33:25-30. 2011..A Phase 2 study to determine the antitumor efficacy of nifurtimox is currently underway...